Results 81 to 90 of about 39,017 (214)

Clopidogrel responsiveness in chronic kidney disease patients with acute coronary syndrome [PDF]

open access: yes, 2014
Objective: Cardiovascular diseases are the leading cause of death in patients with chronic kidney disease (CKD). There is conflicting evidence about effect of CKD on clopidogrel responsiveness.
Ali Kemal Kalkan   +7 more
core   +1 more source

Carotid artery dissection linked to intermittent apnoeic swimming: A case–control study

open access: yesExperimental Physiology, EarlyView.
Abstract Internal carotid artery (ICA) dissection is a rare and potentially devastating cause of cerebral ischaemia, initiated by an intimal tear or rupture of the vasa vasorum, that can lead to an intraluminal thrombus, vascular stenosis, occlusion, or dissecting aneurysm formation.
Damian M. Bailey   +14 more
wiley   +1 more source

Novel strategies for assessing platelet reactivity [PDF]

open access: yes, 2016
There are many approaches to assessing platelet reactivity and many uses for such measurements. Initially, measurements were based on the ability of platelets separated from other blood cells to aggregate together following activation with an appropriate
Dovlatova N   +10 more
core   +2 more sources

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1287-1308, May 2026.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou   +2 more
wiley   +1 more source

Antiplatelet drug resistance in patients with coronary heart disease

open access: yesКардиоваскулярная терапия и профилактика, 2012
Coronary angioplasty is an important component of coronary heart disease (CHD) management. There is a substantial evidence of the need for dual antiaggregant therapy (clopidogrel and aspirin) in this clinical group, both before and after the intervention.
V. A. Sulimov, E. V. Moroz
doaj   +1 more source

Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disorders [PDF]

open access: yes, 2018
Vascular diseases such as myocardial infarction and ischemic stroke are associated with increased platelet function whilst the risk of recurrence is reduced by antiplatelet agents such as aspirin, clopidogrel, and prasugrel.
Adamany J   +15 more
core   +2 more sources

Progressive Rapid Atherosclerotic Plaque Formation and Early Stent re‐Stenosis in an Untreated CLL Patient; A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT A 66 year‐old male with a history of hypertension and poor follow‐up for chronic lymphocytic leukemia (CLL) experienced two episodes of non‐ST elevation myocardial infarction (NSTEMI) within a 6 month period. Initial coronary angiography showed two‐vessel disease, and percutaneous coronary intervention (PCI) was performed on the left anterior ...
Mohammad Shojae   +4 more
wiley   +1 more source

CLOPIDOGREL PHARMACOGENETICS

open access: yesРациональная фармакотерапия в кардиологии, 2016
Platelets play an important role in the pathogenesis of atherosclerosis. They are involved in atherosclerosis progression and thrombotic complications. That is why antiplatelet therapy is a necessary element of these complications prevention in patients ...
A. N. Meshkov
doaj   +1 more source

Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1371-1381, May 2026.
The World Health Organization Model Essential Medicines List and African national essential medicines lists (EMLs) detail drugs intended to be consistently available within national health systems, thereby supporting clinicians and pharmacists in making evidence‐based treatment decisions.
Tinashe A. Mazhindu   +5 more
wiley   +1 more source

Antiplatelet Drug Resistance: Almost Ready for Prime Time [PDF]

open access: yes, 2006
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90218/1/phco.26.8.1201 ...
Dorsch, Michael P., Dunn, Steven P.
core   +1 more source

Home - About - Disclaimer - Privacy